David J Huggins

David J Huggins

Cornell University

H-index: 28

North America-United States

About David J Huggins

David J Huggins, With an exceptional h-index of 28 and a recent h-index of 20 (since 2020), a distinguished researcher at Cornell University, specializes in the field of Computer-Aided Drug Design, Drug Discovery, Statistical Thermodynamics, Molecular Simulations, Computational Biophysics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Lead Optimization of Small Molecule ENL YEATS Inhibitors to Enable In Vivo Studies: Discovery of TDI-11055

BAT2: An open-source tool for flexible, automated and low cost absolute binding free energy calculations

Inhibitors of mycobacterium tuberculosis lipoamide dehydrogenase

Scaffold Hopping and Optimization of Small Molecule Soluble Adenyl Cyclase Inhibitors Led by Free Energy Perturbation

On-demand male contraception via acute inhibition of soluble adenylyl cyclase

Inhibitors of enl/af9 yeats

Shape-Based Virtual Screening of a Billion-Compound Library Identifies Mycobacterial Lipoamide Dehydrogenase Inhibitors

Enhancing hit discovery in virtual screening through absolute protein–ligand binding free-energy calculations

David J Huggins Information

University

Position

Tri-Institutional Therapeutics Discovery Institute/Weill Cornell Medicine

Citations(all)

2549

Citations(since 2020)

1506

Cited By

1620

hIndex(all)

28

hIndex(since 2020)

20

i10Index(all)

45

i10Index(since 2020)

40

Email

University Profile Page

Google Scholar

David J Huggins Skills & Research Interests

Computer-Aided Drug Design

Drug Discovery

Statistical Thermodynamics

Molecular Simulations

Computational Biophysics

Top articles of David J Huggins

Title

Journal

Author(s)

Publication Date

Lead Optimization of Small Molecule ENL YEATS Inhibitors to Enable In Vivo Studies: Discovery of TDI-11055

ACS Medicinal Chemistry Letters

Mayako Michino

Tanweer A Khan

Michael W Miller

Yoshiyuki Fukase

Jeremie Vendome

...

2024/3/12

BAT2: An open-source tool for flexible, automated and low cost absolute binding free energy calculations

Germano Heinzelmann

David Huggins

Michael Gilson

2024/2/20

Inhibitors of mycobacterium tuberculosis lipoamide dehydrogenase

2024/4/25

Scaffold Hopping and Optimization of Small Molecule Soluble Adenyl Cyclase Inhibitors Led by Free Energy Perturbation

Journal of chemical information and modeling

Shan Sun

Makoto Fushimi

Thomas Rossetti

Navpreet Kaur

Jacob Ferreira

...

2023/4/15

On-demand male contraception via acute inhibition of soluble adenylyl cyclase

Nature communications

Melanie Balbach

Thomas Rossetti

Jacob Ferreira

Lubna Ghanem

Carla Ritagliati

...

2023/2/14

Inhibitors of enl/af9 yeats

2023/1/26

Shape-Based Virtual Screening of a Billion-Compound Library Identifies Mycobacterial Lipoamide Dehydrogenase Inhibitors

ACS Bio & Med Chem Au

Mayako Michino

Alexandre Beautrait

Nicholas A Boyles

Aparna Nadupalli

Alexey Dementiev

...

2023/9/8

Enhancing hit discovery in virtual screening through absolute protein–ligand binding free-energy calculations

Journal of Chemical Information and Modeling

Wei Chen

Di Cui

Steven V Jerome

Mayako Michino

Eelke B Lenselink

...

2023/5/11

PYRROLO [2, 3-b] PYRIDINE-3-CARBOXAMIDE COMPOSITIONS AND METHODS FOR AMELIORATING HEARING LOSS

2023/5/4

Assessing the effect of forcefield parameter sets on the accuracy of relative binding free energy calculations

Frontiers in Molecular Biosciences

Shan Sun

David J Huggins

2022/9/12

Development of an improved inhibitor of Lats kinases to promote regeneration of mammalian organs

Proceedings of the National Academy of Sciences

Nathaniel R Kastan

Sanyukta Oak

Rui Liang

Leigh Baxt

Robert W Myers

...

2022/7/8

Comparing the performance of different AMBER protein forcefields, partial charge assignments, and water models for absolute binding free energy calculations

Journal of Chemical Theory and Computation

David J Huggins

2022/3/10

A chemical strategy toward novel brain-penetrant EZH2 inhibitors

ACS Medicinal Chemistry Letters

Rui Liang

Daisuke Tomita

Yusuke Sasaki

John Ginn

Mayako Michino

...

2022/2/10

Design, synthesis, and pharmacological evaluation of second-generation soluble adenylyl cyclase (sAC, ADCY10) inhibitors with slow dissociation rates

Chao-Yun Cai

2021

Small-molecule inhibition of the acyl-lysine reader ENL as a strategy against acute myeloid leukemia

Cancer discovery

Yiman Liu

Qinglan Li

Fatemeh Alikarami

Declan R Barrett

Leila Mahdavi

...

2022/11/2

Small-molecule inhibition of Lats kinases may promote Yap-dependent proliferation in postmitotic mammalian tissues

Nature communications

Nathaniel Kastan

Ksenia Gnedeva

Theresa Alisch

Aleksandra A Petelski

David J Huggins

...

2021/5/25

Whole Cell Active Inhibitors of Mycobacterial Lipoamide Dehydrogenase Afford Selectivity over the Human Enzyme through Tight Binding Interactions

ACS Infectious Diseases

John Ginn

Xiuju Jiang

Shan Sun

Mayako Michino

David J Huggins

...

2021/2/2

Deglycase-activity oriented screening to identify DJ-1 inhibitors

RSC Medicinal Chemistry

Igor Maksimovic

Efrat Finkin-Groner

Yoshiyuki Fukase

Qingfei Zheng

Shan Sun

...

2021

Discovery of TDI-10229: a potent and orally bioavailable inhibitor of soluble adenylyl cyclase (sAC, ADCY10)

ACS Medicinal Chemistry Letters

Makoto Fushimi

Hannes Buck

Melanie Balbach

Anna Gorovyy

Jacob Ferreira

...

2021/7/14

A small-molecule inhibitor of the BRCA2-RAD51 interaction modulates RAD51 assembly and potentiates DNA damage-induced cell death

Cell chemical biology

Duncan E Scott

Nicola J Francis-Newton

May E Marsh

Anthony G Coyne

Gerhard Fischer

...

2021/6/17

See List of Professors in David J Huggins University(Cornell University)

Co-Authors

academic-engine